Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly-diagnosed, Ph-negative, CD22-positive,Bb-cell acute lymphoblastic leukemia: Alliance A041703
   QxMD         Google Scholar   
Citation:
Hemasphere vol 7 (Suppl ) S117
Meeting Instance:
EHA 2023
Year:
2023
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180820 (EA)  
Corr. Author:
 
Authors:
                                   
Networks:
 
Study
Alliance-A041703
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: